Scientists at the University of Ottawa have engineered an enzyme that can specifically cut small, non-coding RNAs, shedding light on their functions and paving the way for potential therapeutic applications. The new enzyme could be a powerful tool for studying these important RNA species.
SourceUniversity of Ottawa·JournalNature Communications·TypeCase study·DateJun 24, 2023
Researchers have improved the FDA's equation for predicting drug interactions by addressing fundamental limitations and incorporating new models. The modified equation has shown a significantly increased accuracy of about 80%, which is expected to contribute to increasing the success rate of new drug development.
SourceInstitute for Basic Science·JournalClinical Pharmacology & Therapeutics·TypeComputational simulation/modeling·DateJan 12, 2023